A compound represented by Formula (1) given below. (In the formula, R.sup.1 represents a hydrogen atom or a methyl group, X.sup.1 represents a C.sub.1 to 9 alkylene group, or a C.sub.3 to 6 alkylene group in which at least one hydrogen is replaced with an acryloxy group or a methacryloxy group, l.sup.1 represents an integer from 0 to 3, Q.sup.1 represents a hydrogen atom or Formula (2) given below (In the formula, R.sup.2 represents a hydrogen atom or a methyl group, X.sup.2 represents a C.sub.1 to 9 alkylene group, or a C.sub.3 to 6 alkylene group in which at least one hydrogen is replaced with an acryloxy group or a methacryloxy group, l.sup.2 represents an integer from 0 to 3, and * represents a bonding site), and Q.sup.2 represents a hydrogen atom or Formula (3) given below (In the formula, R.sup.3 represents a hydrogen atom or a methyl group, X.sup.3 represents a C.sub.1 to 9 alkylene group, or a C.sub.3 to 6 alkylene group in which at least one hydrogen is replaced with an acryloxy group or a methacryloxy group, l.sup.3 represents an integer from 0 to 3, and * represents a bonding site).)

A compound represented by Formula (1) given below. (In the formula, R.sup.1 represents a hydrogen atom or a methyl group, X.sup.1 represents a C.sub.1 to 9 alkylene group, or a C.sub.3 to 6 alkylene group in which at least one hydrogen is replaced with an acryloxy group or a methacryloxy group, l.sup.1 represents an integer from 0 to 3, Q.sup.1 represents a hydrogen atom or Formula (2) given below (In the formula, R.sup.2 represents a hydrogen atom or a methyl group, X.sup.2 represents a C.sub.1 to 9 alkylene group, or a C.sub.3 to 6 alkylene group in which at least one hydrogen is replaced with an acryloxy group or a methacryloxy group, l.sup.2 represents an integer from 0 to 3, and * represents a bonding site), and Q.sup.2 represents a hydrogen atom or Formula (3) given below (In the formula, R.sup.3 represents a hydrogen atom or a methyl group, X.sup.3 represents a C.sub.1 to 9 alkylene group, or a C.sub.3 to 6 alkylene group in which at least one hydrogen is replaced with an acryloxy group or a methacryloxy group, l.sup.3 represents an integer from 0 to 3, and * represents a bonding site).)

The present invention provides a paste-like composition for dental use that shows stable consistency and runniness and little stringiness immediately after production and even after long storage. The present invention relates to a paste-like composition for dental use, comprising a polymerizable monomer (A) and a filler (B), the filler (B) comprising a particulate filler (B-1) having an average primary particle diameter of 0.001 to 0.2 μm, and a filler (B-2) having an average primary particle diameter of more than 0.2 μm and 30 μm or less, the paste-like composition having a consistency of 15 to 40 mm, the particulate filler (B-1) having an average secondary particle diameter of 20 μm or less.

The present invention provides a paste-like composition for dental use that shows stable consistency and runniness and little stringiness immediately after production and even after long storage. The present invention relates to a paste-like composition for dental use, comprising a polymerizable monomer (A) and a filler (B), the filler (B) comprising a particulate filler (B-1) having an average primary particle diameter of 0.001 to 0.2 μm, and a filler (B-2) having an average primary particle diameter of more than 0.2 μm and 30 μm or less, the paste-like composition having a consistency of 15 to 40 mm, the particulate filler (B-1) having an average secondary particle diameter of 20 μm or less.

A manufacturing method of a sliding member for an artificial joint according to the present disclosure includes exposing a base member with ultraviolet rays in a state where the base member is in contact with an aqueous treatment solution containing a compound having 0.20 mol/L or more and less than 0.50 mol/L of phosphorylcholine group and a water-soluble inorganic salt.

A manufacturing method of a sliding member for an artificial joint according to the present disclosure includes exposing a base member with ultraviolet rays in a state where the base member is in contact with an aqueous treatment solution containing a compound having 0.20 mol/L or more and less than 0.50 mol/L of phosphorylcholine group and a water-soluble inorganic salt.

A dental material having (a) at least one radically polymerizable monomer, (b) at least one radiopaque filler, (c) at least one inorganic filler, (d) at least one composite filler, and (e) at least one initiator for the radical polymerization, wherein the monomer (a) comprises at least one urethane (meth)acrylate, at least one radically polymerizable bisphenol A derivative, optionally at least one polycyclic aliphatic dimethacrylate, optionally at least one monomer which does not fall into one of the groups (a-1) to (a-3) and (a-5), and optionally at least one chain regulator (a-5). The dental material allows the fabrication of esthetically pleasing restorations with only one material.

A dental material having (a) at least one radically polymerizable monomer, (b) at least one radiopaque filler, (c) at least one inorganic filler, (d) at least one composite filler, and (e) at least one initiator for the radical polymerization, wherein the monomer (a) comprises at least one urethane (meth)acrylate, at least one radically polymerizable bisphenol A derivative, optionally at least one polycyclic aliphatic dimethacrylate, optionally at least one monomer which does not fall into one of the groups (a-1) to (a-3) and (a-5), and optionally at least one chain regulator (a-5). The dental material allows the fabrication of esthetically pleasing restorations with only one material.

A biomedical device is disclosed. The biomedical device includes a polymerization product of a biomedical device-forming mixture containing (a) one or more grafted glycosaminoglycan polymers including a glycosaminoglycan having a polymer backbone and one or more side chains comprising an ethylenically unsaturated reactive-containing residue grafted onto the polymer backbone, and (b) one or more non-silicone biomedical device-forming monomers.

A biomedical device is disclosed. The biomedical device includes a polymerization product of a biomedical device-forming mixture containing (a) one or more grafted glycosaminoglycan polymers including a glycosaminoglycan having a polymer backbone and one or more side chains comprising an ethylenically unsaturated reactive-containing residue grafted onto the polymer backbone, and (b) one or more non-silicone biomedical device-forming monomers.